July Rodríguez

985 total citations
18 papers, 333 citations indexed

About

July Rodríguez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, July Rodríguez has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in July Rodríguez's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Research Studies (4 papers). July Rodríguez is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (4 papers) and Lung Cancer Research Studies (4 papers). July Rodríguez collaborates with scholars based in Colombia, Spain and Mexico. July Rodríguez's co-authors include Óscar Arrieta, Andrés F. Cardona, Luis Corrales, Carlos Vargas, Hernán Carranza, Jorge Otero, Rafael Rosell, Alejandro Ruíz-Patiño, Zyanya Lucía Zatarain-Barrón and Luisa Ricaurte and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Discovery and Oncotarget.

In The Last Decade

July Rodríguez

16 papers receiving 330 citations

Peers

Countries citing papers authored by July Rodríguez

Since Specialization

Citations

This map shows the geographic impact of July Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by July Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites July Rodríguez more than expected).

Fields of papers citing papers by July Rodríguez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by July Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by July Rodríguez. The network helps show where July Rodríguez may publish in the future.

Co-authorship network of co-authors of July Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of July Rodríguez. A scholar is included among the top collaborators of July Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with July Rodríguez. July Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors 2024 ·JCO Global Oncology ·(unknown), (unknown), Alejandro Ruíz-Patiño, (unknown), July Rodríguez, Darwin A. Moreno‐Pérez, (unknown), Jorge Otero, Carlos A. Vargas, Pilar Archila, Leonardo Rojas, (unknown), (unknown), Camila Ordóñez‐Reyes, Juan Esteban García-Robledo, (unknown), (unknown), Óscar Arrieta, Andrés F. Cardona	2
2	When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review 2021 ·Oncology and Therapy ·July Rodríguez, (unknown), Christian Rolfo, Alejandro Ruíz-Patiño, Alessandro Russo, Luisa Ricaurte, Camila Ordóñez‐Reyes, Óscar Arrieta, Zyanya Lucía Zatarain-Barrón, Gonzalo Recondo, Andrés F. Cardona	50
3	Paleo-oncología 2021 ·July Rodríguez, Alejandro Ruíz-Patiño, (unknown), (unknown), (unknown), (unknown), Tatiana Gómez, Óscar Arrieta, (unknown), Camila Ordóñez‐Reyes, Andrés F. Cardona	1
4	P59.14 Concordance and Performance of ddPCR Compared to NGS for The Detection of KRAS G12C Mutation 2021 ·Journal of Thoracic Oncology ·Alejandro Ruíz-Patiño, July Rodríguez, (unknown), Pilar Archila, Andrés F. Cardona, Cármen G. Sotelo, Hernán Carranza, (unknown), Jorge Otero, María A. Bermúdez, (unknown), Óscar Arrieta, (unknown), Luis Corrales, (unknown), Juan Esteban García-Robledo, (unknown), Christian Rolfo, Rafael Rosell	0
5	Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations 2020 ·Cancer Discovery ·Jian Carrot‐Zhang, Giovanny Soca‐Chafre, Nick Patterson, Aaron R. Thorner, Anwesha Nag, Jacqueline Watson, Giulio Genovese, July Rodríguez, (unknown), Luis Corrales, Yoichiro Mitsuishi, Gavin Ha, Joshua D. Campbell, Geoffrey R. Oxnard, Óscar Arrieta, Andrés F. Cardona, Alexander Gusev, Matthew Meyerson	71
6	Human papillomavirus infection in metastatic lung adenocarcinoma is associated with better outcomes with immune checkpoint inhibitor treatment. 2020 ·Journal of Clinical Oncology ·(unknown), Alejandro Ruíz-Patiño, (unknown), July Rodríguez, (unknown), (unknown), Zyanya Lucía Zatarain-Barrón, Óscar Arrieta, Feliciano Barrón, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, (unknown), Claudio Martín, Luís Pino, Christian Rolfo, Rafael Rosell, Andrés F. Cardona, Gonzalo Recondo	1
7	Mortality and Advanced Support Requirement for Patients With Cancer With COVID-19: A Mathematical Dynamic Model for Latin America 2020 ·JCO Global Oncology ·Alejandro Ruíz-Patiño, Óscar Arrieta, Luís Pino, Christian Rolfo, Luisa Ricaurte, Gonzalo Recondo, (unknown), Luis Corrales, Claudio Martín, Feliciano Barrón, Carlos Vargas, Hernán Carranza, Jorge Otero, July Rodríguez, (unknown), Lucía Viola, Alessandro Russo, R. Rosell, Andrés F. Cardona	9
8	Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP) 2019 ·Frontiers in Oncology ·Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Alejandro Ruíz-Patiño, Luisa Ricaurte, Luis Corrales, Claudio Martín, H. Freitas, Vladmir Cláudio Cordeiro de Lima, July Rodríguez, (unknown), (unknown), Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Feliciano Barrón, Niki Karachaliou, Rafael Rosell, Óscar Arrieta	22
9	AXL and CDCP1: A roadmap of innate resistance in EGFR mutant NSCLC. 2018 ·Journal of Clinical Oncology ·Niki Karachaliou, Imane Chaib, Andrés F. Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Ana Drozdowskyj, Ilaria Attili, July Rodríguez, (unknown), Santiago Viteri, Sai‐Hong Ignatius Ou, Tony Mok, Trever G. Bivona, Mayumi Ono, Jingrong Jean Cui, Peng Cao, Rafael Rosell	1
10	EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) 2018 ·Targeted Oncology ·Alejandro Ruíz-Patiño, (unknown), Luisa Ricaurte, Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Beatriz Wills, Noemı́ Reguart, Hernán Carranza, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martín, Pilar Archila, July Rodríguez, (unknown), (unknown), Luís Pino, Rafael Rosell, Óscar Arrieta	26
11	P1.02-055 Genotyping Squamous Cell Lung Carcinoma Among Hispanics (Geno1.1-CLICaP) 2017 ·Journal of Thoracic Oncology ·Andrés F. Cardona, Óscar Arrieta, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Luis Corrales, Claudio Martín, July Rodríguez, J. Rodríguez, Pilar Archila, (unknown), Rafael Rosell	0
12	Genotyping low-grade gliomas among Hispanics 2016 ·Neuro-Oncology Practice ·Andrés F. Cardona, Leonardo Rojas, Beatriz Wills, (unknown), (unknown), Fernando Hakim, (unknown), (unknown), Óscar Arrieta, (unknown), (unknown), Hernán Carranza, Carlos Vargas, Jorge Otero, Diego González, July Rodríguez, León Darío Ortiz, (unknown), Carmen Balañá	2
13	BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations 2016 ·Oncotarget ·Andrés F. Cardona, (unknown), Leonardo Rojas, Beatriz Wills, Óscar Arrieta, Hernán Carranza, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martín, Noemı́ Reguart, Pilar Archila, July Rodríguez, Mauricio Cuello, (unknown), Sandra Franco, Christian Rolfo, Rafael Rosell	22
14	The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer 2014 ·Lung Cancer ·Óscar Arrieta, Andrés F. Cardona, Luis Corrales, Alma D. Campos-Parra, Roberto Sánchez-Reyes, (unknown), July Rodríguez, Carlos Vargas, Hernán Carranza, Jorge Otero, (unknown), (unknown), Rafael Rosell	68
15	Genotyping melanoma in Colombia. 2014 ·Journal of Clinical Oncology ·Hernán Carranza, Andrés F. Cardona, Carlos Vargas, Pilar Archila, Jorge Otero, (unknown), July Rodríguez, (unknown), (unknown), (unknown), (unknown), (unknown), Mauricio Lema, (unknown), (unknown), A.F. Yepes, Leonardo Rojas, Ricardo Jordão Duarte, (unknown), Óscar Arrieta	1
16	Extended-schedule dose-dense temozolomide in refractory gliomas 2009 ·Journal of Neuro-Oncology ·(unknown), Alfonso Berrocal, Pedro Pérez Segura, (unknown), Carmen Balañá, (unknown), Ricardo Yayá, July Rodríguez, Gaspar Reynés, Óscar Gallego, L. Iglesias	46
17	Phase II study of extended schedule temozolomide in refractory gliomas 2006 ·Journal of Clinical Oncology ·Alfonso Berrocal, Pedro Pérez‐Segura, Marta Gil, Carmen Balañá, Ricardo Yayá, July Rodríguez, Gaspar Reynés, (unknown), Óscar Gallego	8
18	P-485 EGFR mutations do not accurately predict response to erlotinib in first-line monotherapy treatment of advanced non-small-cell lung cancer 2005 ·Lung Cancer ·Giuseppe Giaccone, Maarten L. Janmaat, Mariëlle Gallegos Ruiz, July Rodríguez, T. Lechevalier, Nicholas Thatcher, Egbert F. Smit, (unknown), Jean‐Charles Soria	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact